UKBizDB.co.uk

PANDEIA THERAPEUTICS LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Pandeia Therapeutics Limited. The company was founded 6 years ago and was given the registration number 11463856. The firm's registered office is in CAMBRIDGE. You can find them at C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:PANDEIA THERAPEUTICS LIMITED
Company Number:11463856
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:13 July 2018
End of financial year:31 August 2022
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Moneta, Babraham Reserach Campus, Babraham, Cambridge, England, CB22 3AT

Corporate Secretary09 August 2019Active
C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH

Director22 December 2022Active
C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH

Director19 September 2019Active
C/O The Cambridge Partnership Ltd,, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, United Kingdom, CB22 3FH

Director19 September 2019Active
C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Babraham, Cambridge, England, CB22 3AT

Director05 March 2019Active
C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Babraham, Cambridge, England, CB22 3AT

Director05 March 2019Active
Biohub, Alderley Park, Macclesfield, England, SK10 4TG

Director13 July 2018Active

People with Significant Control

Acadia Pharmaceuticals Inc.
Notified on:22 December 2022
Status:Active
Country of residence:United States
Address:12830, El Camino Real, San Diego, United States,
Nature of control:
  • Ownership of shares 75 to 100 percent
Medicxi Ventures I Lp
Notified on:20 September 2019
Status:Active
Country of residence:Jersey
Address:44, Esplanade, St Helier, Jersey, Jersey, JE4 9WG
Nature of control:
  • Ownership of shares 75 to 100 percent
Dr Fraser Murray
Notified on:05 March 2019
Status:Active
Date of birth:May 1971
Nationality:British
Country of residence:England
Address:C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
  • Right to appoint and remove directors
Dr Martin Quibell
Notified on:05 March 2019
Status:Active
Date of birth:July 1966
Nationality:British
Country of residence:England
Address:C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent
  • Right to appoint and remove directors
Dr Timothy Schulz-Utermoehl
Notified on:13 July 2018
Status:Active
Date of birth:October 1972
Nationality:German
Country of residence:England
Address:C/O The Cambridge Partnership, Moneta, Babraham Research Campus, Cambridge, England, CB22 3AT
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (3 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (1 months remaining)

Copyright © 2024. All rights reserved.